| Reference | FOI 2025/1207 |
|---|---|
| Description | Inquiry on Myocardial Perfusion Imaging Procedures and Regadenoson Usage |
| Date Requested | 25/04/2025 |
| Date Replied | 01/05/2025 |
| Category | Strategic Clinical Networks (SCN) |
I attempted to gather data on the number of Myocardial Perfusion Imaging (MPI) procedures & Regadenoson usage in the UK but found limited information from the sources.
So, I would like to inquire about the following:
Scope of my request: As a pharmaceutical company, we are currently conducting a comprehensive portfolio evaluation to identify new opportunities for product development and introduction into the UK market. We have identified the diagnostic sector, particularly the cardiac imaging segment, as a promising area due to the increasing prevalence of cardiovascular disease within the population. To better understand the market potential and make informed decisions, we require additional data and insights
NHS Greater Manchester (NHS GM) does not hold the information requested. Therefore, it will be necessary for you to direct your request to the NHS health care provider organisations for the information you seek. To assist you please find below links to the trust websites and information about how to make a Freedom of Information request.